scispace - formally typeset
E

Erik C. Dreaden

Researcher at Massachusetts Institute of Technology

Publications -  68
Citations -  10953

Erik C. Dreaden is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Immune system & Immunology. The author has an hindex of 30, co-authored 57 publications receiving 9049 citations. Previous affiliations of Erik C. Dreaden include Emory University & Georgia Institute of Technology.

Papers
More filters
Journal ArticleDOI

The golden age: gold nanoparticles for biomedicine

TL;DR: It is argued that gold nanotechnology-enabled biomedicine is not simply an act of 'gilding the (nanomedicinal) lily', but that a new 'Golden Age' of biomedical nanotechnology is truly upon us.
Journal ArticleDOI

Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice.

TL;DR: The present work demonstrates the feasibility of in vivo PPTT treatment of deep-tissue malignancies using easily-prepared plasmonic gold nanorods and a small, portable, inexpensive near-infrared (NIR) laser.
Journal ArticleDOI

The Golden Age: Gold Nanoparticles for Biomedicine

TL;DR: Gold nanoparticles have been used in biomedical applications since their first colloidal syntheses more than three centuries ago as discussed by the authors and they exhibit physical properties that are truly different from both small molecules and bulk materials, as well as from other nanoscale particles.
Journal ArticleDOI

Beating cancer in multiple ways using nanogold

TL;DR: This tutorial review will highlight some of the many forms and recent applications of these gold nanoparticle conjugates by the lab and others, as well as their rational design and physiologic interactions.